Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL

Emerging evidence shows that tumor cells secrete extracellular vesicles (EVs) that carry bioactive cell surface markers, such as programmed death-ligand 1 (PD-L1), which can modulate immune responses and inhibit anti-tumor responses, potentially playing a role in lymphomagenesis and in promoting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez, Laura E., Lensing, Shelly, Chang, Di, Magpantay, Larry I., Mitsuyasu, Ronald, Ambinder, Richard F., Sparano, Joseph A., Martínez-Maza, Otoniel, Epeldegui, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163074/
https://www.ncbi.nlm.nih.gov/pubmed/35655072
http://dx.doi.org/10.1038/s41598-022-13101-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163074/
https://www.ncbi.nlm.nih.gov/pubmed/35655072
http://dx.doi.org/10.1038/s41598-022-13101-8

Ejemplares similares